Sort
82,697 grants matching “vaccine development”
Synthesis of Antitumor Natural Products
$771,834Samuel J Danishefsky · Sloan-Kettering Inst Can Research · R37 · FY2011 · CA
Investigating Syphilis Pathogenesis Through Genetic Engineering of Treponema pallidum
$771,690Lorenzo Giacani · University Of Washington · R56 · FY2024 · AI
GBS mediated in utero fetal injury
$771,648Lakshmi Rajagopal · Seattle Children'S Hospital · R01 · FY2014 · AI
Hydrogel-Based Aged Immune Organoids to Study Epigenetics and Trajectory of B Cells
$771,620Ankur Singh · Georgia Institute Of Technology · R01 · FY2024 · AI
Network-based study design, statistical, and modeling solutions for HIV among populations that use illicit substances: Informing interventions and policy in real-world settings using existing data
$771,618Ashley Lynn Buchanan · University Of Rhode Island · R01 · FY2024 · DA
Neoantigen Vaccination for Lynch Syndrome Immunoprevention
$771,608Steven Monroe Lipkin · Weill Medical Coll Of Cornell Univ · U01 · FY2020 · CA
ANTIBODY EFFECTOR FUNCTION IN PROTECTION AGAINST HIV-1
$771,584Scripps Research Institute · R01 · FY2003 · AI
BKV and JCV vaccine development
$771,566Christopher Buck · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Molecular biology of human polyomaviruses
$771,566Christopher Buck · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Long-term Effects of Health and Development Interventions in Rural Bangladesh
$771,467Jane A Menken · University Of Colorado · R01 · FY2012 · AG
Clinical Interventional Studies of HIV Reservoirs
$771,465Frank Maldarelli · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Preclinical Studies and Mucosal Responses
$771,455Rama Rao Amara · Geovax, Inc. · U19 · FY2008 · AI
Cervicovaginal microbiome, mucosal immunity, and pathogen factors that contribute to spontaneous clearance of Chlamydia trachomatis
$771,416Rebecca M. Brotman · University Of Maryland Baltimore · R01 · FY2024 · AI
Anti-flavivirus B cell response analysis to aid vaccine design
$771,355Yuxing Li · University Of Maryland Baltimore · R01 · FY2024 · AI
Mapping and modeling host-pathogen interactions in TB latency and reactivation
$771,347Maria Laura Gennaro · Univ Of Med/Dent Of Nj-Nj Medical School · R01 · FY2010 · HL
Preclinical development of human CMV vaccines
$771,327Michael A McVoy · Virginia Commonwealth University · R01 · FY2014 · AI
Immune diagnostics and vaccine targets: breast cancer antigens from mice to women
$771,321Mary L. Disis · University Of Washington · U01 · FY2010 · CA
Syrian hamsters as an animal model for influenza virus research
$771,313Yoshihiro Kawaoka · University Of Wisconsin-Madison · R01 · FY2021 · AI
Targeting early metastable intermediates of the SARS-CoV-2 spike for vaccine and therapeutics development
$771,293Priyamvada Acharya · Duke University · R01 · FY2021 · AI
Evaluation of pregnancy on vaccine-induced immunity and protection in a pre-clinical model of RSV infection
$771,241Karen A Norris · University Of Georgia · R01 · FY2021 · AI
Clinical Core
$771,188Cornelia L Dekker · Stanford University · U19 · FY2010 · AI
Combinatorial and computational design of bnAb mRNA vaccines for HIV
$771,167Daniel G Anderson · Massachusetts Institute Of Technology · R33 · FY2025 · AI
Primary Care Based Depression Prevention in Adolescents: Intervention Optimization in Preparation for Implementation Study
$771,161Benjamin W Van Voorhees · University Of Illinois At Chicago · R01 · FY2021 · MH
Investigating and identifying the heterogeneity in COVID-19 misinformation exposure on social media among Black and Rural communities to inform precision public health messaging
$771,159Sharath Chandra Guntuku · University Of Pennsylvania · R01 · FY2024 · MD
Collaborative Research: Ideas Lab: The Role of Extracellular RNA in Intercellular and Interkingdom Communication
$771,071Erica L Westerman · University Of Arkansas · · FY2023 · BIO